Cargando…

A Biobank of Colorectal Cancer Patient-Derived Xenografts

Colorectal cancer (CRC) is a challenging disease, with a high mortality rate and limited effective treatment options, particularly for late-stage disease. Patient-derived xenografts (PDXs) have emerged as an informative, renewable experimental resource to model CRC architecture and biology. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdirahman, Suad M., Christie, Michael, Preaudet, Adele, Burstroem, Marie C. U., Mouradov, Dmitri, Lee, Belinda, Sieber, Oliver M., Putoczki, Tracy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563543/ https://www.ncbi.nlm.nih.gov/pubmed/32825052 http://dx.doi.org/10.3390/cancers12092340

Ejemplares similares

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
por: Ernst, Matthias, et al.
Publicado: (2015)

Confocal laser endomicroscopy to monitor the colonic mucosa of mice
por: Mielke, Lisa, et al.
Publicado: (2015)

Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancer
por: Nguyen, Paul M., et al.
Publicado: (2019)

MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer
por: Sakthianandeswaren, Anuratha, et al.
Publicado: (2018)

Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
por: Salita, Timothy, et al.
Publicado: (2022)

Fecal DNA Virome Is Associated with the Development of Colorectal Neoplasia in a Murine Model of Colorectal Cancer
por: Li, Yingshi, et al.
Publicado: (2022)

Type 2 Innate Lymphoid Cells Protect against Colorectal Cancer Progression and Predict Improved Patient Survival
por: Huang, Qiutong, et al.
Publicado: (2021)

PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P(3) Effector Signaling in Colorectal Cancer
por: Palmieri, Michelle, et al.
Publicado: (2023)

A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
por: Xu, Xiaoxi, et al.
Publicado: (2023)

The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models
por: Tanaka, Kuniaki, et al.
Publicado: (2022)

Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC
por: Faux, Maree C., et al.
Publicado: (2022)

Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth
por: Tan, Fiona H., et al.
Publicado: (2018)

TB-08 PATIENT DERIVED XENOGRAFT’S BIOBANK FROM KANSAI MOLECULAR DIAGNOSIS NETWORK FOR CENTRAL NERVOUS SYSTEM TUMORS
por: Kijima, Noriyuki, et al.
Publicado: (2019)

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors
por: Marques Da Costa, Maria Eugénia, et al.
Publicado: (2023)

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression
por: Hutten, Stefan J., et al.
Publicado: (2023)

S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer
por: Low, Ronnie Ren Jie, et al.
Publicado: (2023)

Correction to: S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer
por: Low, Ronnie Ren Jie, et al.
Publicado: (2023)

Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients
por: Koo, Kendrick, et al.
Publicado: (2021)

Patient‐derived xenograft model in colorectal cancer basic and translational research
por: Liu, Xiaofeng, et al.
Publicado: (2022)

Preparation and application of patient-derived xenograft mice model of colorectal cancer
por: Zhang, Yutao, et al.
Publicado: (2023)

Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods
por: Alkema, Nicolette G., et al.
Publicado: (2015)

The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
por: Low, Ronnie Ren Jie, et al.
Publicado: (2021)

Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models
por: Gock, Michael, et al.
Publicado: (2016)

A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data
por: Yau, Christopher, et al.
Publicado: (2010)

Low-viscosity matrix suspension culture enables scalable analysis of patient-derived organoids and tumoroids from the large intestine
por: Hirokawa, Yumiko, et al.
Publicado: (2021)

Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer
por: Lu, Min, et al.
Publicado: (2018)

Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion
por: Sengupta, Neel, et al.
Publicado: (2013)

Targeting IL-11 signaling in colon cancer
por: Ernst, Matthias, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review
por: Brown, Kai M., et al.
Publicado: (2016)

Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts
por: van der Heijden, Maartje, et al.
Publicado: (2019)

Capturing colorectal cancer inter‐tumor heterogeneity in patient‐derived xenograft (PDX) models
por: Prasetyanti, Pramudita R., et al.
Publicado: (2018)

Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research
por: Inoue, Akira, et al.
Publicado: (2019)

Zebrafish Patient-Derived Xenograft Model to Predict Treatment Outcomes of Colorectal Cancer Patients
por: Di Franco, Gregorio, et al.
Publicado: (2022)

Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
por: Jarnicki, Andrew, et al.
Publicado: (2010)

Turmeric Is Therapeutic in Vivo on Patient-Derived Colorectal Cancer Xenografts: Inhibition of Growth, Metastasis, and Tumor Recurrence
por: Li, Mingyue, et al.
Publicado: (2021)

STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?
por: Nguyen, Paul M., et al.
Publicado: (2015)

The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank
por: Guerrera, Francesco, et al.
Publicado: (2016)

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
por: Garner, Evan F., et al.
Publicado: (2018)

Phenotypic and Transcriptional Fidelity of Patient-Derived Colon Cancer Xenografts in Immune-Deficient Mice
por: Chou, Jeffrey, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tfa0b082i791eg9sumlfecb290